Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Left uterine artery" patented technology

The uterine artery usually arises from the anterior division of the internal iliac artery. It travels to the uterus, crossing the ureter anteriorly,to the uterus by traveling in the cardinal ligament. Uterine artery. It travels through the parametrium of the inferior broad ligament of the uterus.

Multi-axial uterine artery identification, characterization, and occlusion pivoting devices and methods

A system is provided for compressing one or both of the uterine arteries of a patient which is at least in part shaped to complement the shape of the exterior of the cervix, which allows the system to be self-positioning. One or more Doppler chips can be mounted or incorporated into the system which permit the practitioner to better identify the uterine artery and monitor blood flow therein. The system includes a pair of pivotally joined elements which can be moved toward and away from the cervix to compress a uterine artery.
Owner:VASCULAR CONTROL SYST

Minimally Invasive Methods and Apparatus for Accessing and Ligating Uterine Arteries with Sutures

InactiveUS20060276808A1Easy accessShorten surgical time and traumaSuture equipmentsSurgical needlesVeinLigament structure
Surgical procedures, tools, and kits particularly suited to effect uterine artery ligation in a minimally invasive manner to treat uterine fibroids or other conditions of the uterus are disclosed. An incision through the fornix is made to access the uterine arteries supported by the cardinal and uterosacral ligaments. A distal end of one or more sutures is passed around each uterine artery and a portion of the ligament supporting and enclosing the uterine artery, wherein the portion may include a uterine vein. The passage is effected by directing a suture distal end along a first side of the portion of the ligament beyond to the fornix incision, then through the ligament, and then back proximally along the second ligament side toward the fornix incision.
Owner:AMS RES CORP

Uterine artery occlusion device with cervical receptacle

InactiveUS20050113852A1Simpler and more readily usedSimpler and more readily and removedBlood flow measurement devicesFemale contraceptivesUterine DisorderDisease
The invention is directed to an intravaginal uterine artery occlusion device for treating uterine disorders such as fibroids, dysfunctional uterine bleeding, postpartum hemorrhage and the like. A occlusion device has a cervical receptacle or cap with an open distal end for receiving the patient's uterine cervix and an elongated shaft having a distal end secured to the closed proximal end of the cervical receptacle and an inner lumen extending to the distal end of the elongated shaft. The patient's uterine cervix is held within the interior of the receptacle by the application of a vacuum to the interior of the receptacle through the inner lumen of the shaft or otherwise, while the leading edge(s) of the cervical receptacle press against the patient's vaginal fornix to occlude an underlying or adjacent uterine artery. At least one blood flow sensor may be provided on the leading edge of the receptacle to aid in locating a uterine artery and to monitor blood flow through the located uterine artery.
Owner:VASCULAR CONTROL SYST

Embolic occlusion of uterine arteries

InactiveUS20040202694A1Decreased blood flowSlow and stop flowSurgical adhesivesFemale contraceptivesWater basedUterine Disorder
A treatment procedure is disclosed which involves the short term, non-permanent occlusion of the patient's blood vessels by depositing a bioabsorbable embolic mass within the patient's blood vessel. The procedure is particularly suitable for treating uterine disorders by occluding a patient's uterine arteries. A therapeutically effective time period for occlusion of a uterine artery is from about 0.5 to about 48 hours, preferably about 1 to about 24 hours, with occlusion times of about 1 to about 8 hours being suitable in many instances. The embolic mass may bioabsorbable particulate with minimum transverse dimensions of about 100 to about 2000 micrometers, preferably about 300 to about 1000 micrometers. The particulate may be a polymeric material formed of polylactic acid, polyglycolic acid or copolymers thereof, or a swellable copolymer of lactic acid and polyethylene glycol. The embolic material may be delivered to an intracorporeal site as a biocompatible solution containing a solute which is relatively insoluble in a water based fluid and a solvent which is relatively soluble in the water based fluid, where the solute forms the embolic mass which occludes or partially occludes a body lumen or fills or partially fills a body cavity.
Owner:VASCULAR CONTROL SYST

Method and apparatus for the detection and ligation of uterine arteries

InactiveUS7229465B2Simpler and more readily used and removedConvenient treatmentBlood flow measurement devicesSurgical instrument detailsUterine DisorderDisease
The invention provides devices, systems and methods for occluding arteries without puncturing skin or vessel walls. The devices, systems and methods for occluding arteries are configured to be applied to arteries externally of the arteries. Occlusion may be temporary or permanent, and may be partial or complete. Clamping a device to tissue near to an artery is effective to compress tissue around the artery and to indirectly compress the artery. The methods, devices and systems of the invention find use in, for example, treatment of uterine disorders and conditions which may be treated by occlusion of the uterine arteries. A uterine artery may be accessed via a patient's vagina by compressing a portion of the vaginal wall around a portion of a uterine artery to occlude a uterine artery. Clamping of an artery may also be performed by clamping a device directly onto an artery.
Owner:VASCULAR CONTROL SYST

Occlusion device for asymmetrical uterine artery anatomy

InactiveUS20050113634A1Effective therapeutic treatmentEfficient use ofSurgical veterinaryObstetrical instrumentsObstetricsBlood flow
An occluding device is disclosed for occluding a female patient's uterine arteries which have unsymmetrical anatomy with respect to the patient's uterine cervix. The occluding device has a pair of pivotally connected occluding members, with at least one of the occluding member having a movable occluding element on a distal shaft section of the occluding member. The position and orientation of the occluding elements on the distal shaft sections may be adjusted by operative members on the proximal shaft sections of the occluding members to accommodate for asymmetrical uterine artery anatomy. The occluding elements have pressure applying surfaces with one or more blood flow sensors such as Doppler chips which help the physician to better identify the uterine artery and to monitor blood flow therein. A tenaculum-like guiding element configured to be secured within the patient's uterine cervix, may be provided to guide the occluding device to the patient's cervix.
Owner:VASCULAR CONTROL SYST

Vascular clamp for caesarian section

ActiveUS20050101974A1Easy to usePrevent excessive blood lossBlood flow measurement devicesCatheterCaesarian sectionArtery forceps
The invention provides devices, systems and methods for clamping arteries which are useful in reducing or abolishing blood flow in an artery, and may be used to control hemorrhage following a caesarian delivery. A clamping device embodying features of the invention includes a pair of clamping members with opposed pressure-applying members having facing pressure-applying surfaces, at least one of which is a yieldable pressure-applying surface. The yieldable pressure-applying surface is preferably resilient. The clamping members are configured to adjust the distance between pressure-applying surfaces, and a blood flow sensor is disposed on at least one of the pressure-applying members to aid in locating the target artery and also to monitor blood flow through the artery. The clamping device is particularly suitable for occluding uterine arteries by compressing the broad ligament which contains the uterine artery and which is connected to the patient's uterus with the arterial clamp.
Owner:VASCULAR CONTROL SYST

Method and device for canulation and occlusion of uterine arteries

A method for treating a uterine fibroid comprises forming an incision in a vaginal fornix to expose a first blood vessel supplying the fibroid, forming an opening in the first blood vessel and inserting an introducer into the first blood vessel via the opening in combination with the steps of advancing a catheter to a desired position within the first blood vessel via the introducer and introducing an occlusive agent into the first blood vessel through the catheter to block blood flow through the first blood vessel. A device for treating uterine fibroids comprises an elongated sheath sized for insertion into uterine arteries via an incision in the vaginal fornix, the sheath including a sheath lumen extending from a first sheath opening formed in a proximal end of the sheath to a second sheath opening formed in a distal end of the sheath and a body a distal end of which is connected to the proximal end of the sheath, the body including a body lumen extending therethrough from a first body opening at a proximal end of the body and a second body opening at the distal end thereof, the second body lumen communicating with the sheath lumen in combination with a hemostatic valve controlling the flow of blood through the body lumen.
Owner:BOSTON SCI SCIMED INC

Deployable constrictor for uterine artery occlusion

InactiveUS7172603B2Efficient deploymentUndesired movement is also preventedBlood flow measurement devicesCatheterUterine DisorderDisease
Devices, systems and methods for occluding blood vessels include a deployable constrictor having opposed pressure-applying portions, a delivery shaft configured to intravaginally advance the constrictor to the patient's cervix, a location sensor configured to detect a blood vessel, a deployment member for deploying the constrictor about the patient's cervix, and optionally a guide. The constrictor has a first configuration to receive a cervix and a second configuration to apply pressure to the cervical area to occlude a uterine artery by compression from the pressure-applying members. The pressure-applying members may be released from the cervix after a limited therapeutically effective time. The constrictor is for treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries, such as uterine fibroids, dysfunctional uterine bleeding, post-partum hemorrhage, and bleeding associated with caesarian sections.
Owner:VASCULAR CONTROL SYST

Fibroid Treatment Methods and Devices

A system for ligating a uterine artery in a patient generally includes a suture transfer tool, suture transfer darts, and one or more sutures. Others systems and implants are described herein for treating and / or eliminating fibroids or fibrous masses in males and females.
Owner:AMS RES CORP

Method and instrument for occlusion of uterine blood vessels

A method for performing a cesarean section includes the occlusion of uterine arteries using an atraumatic occlusion instrument, for example, an atraumatic clamp, after pulling the uterus from the pelvic cavity and placing it on the patient abdomen, The method significantly reduces blood loss in patients. An atraumatic occlusion clamp has disposable covers made of gauze.
Owner:MACKOVIC BASIC MIRIAM +3

Methods for minimally-invasive, non-permanent occlusion of a uterine artery

Non-permanent occlusion of the uterine arteries is sufficient to cause the demise of uterine myomata without unnecessarily exposing other tissues and anatomical structures to hypoxia attendant to prior permanent occlusion techniques. A therapeutically effective transient time of occlusion of a uterine artery to treat uterine fibroid tumors is from 1 hours to 24 hours, and preferably is at least about 4 hours. A therapeutically effective temporary time of occlusion of a uterine artery to treat uterine fibroid tumors is from 1 day (24 hours) to 7 days (168 hours), and preferably is about 4 days (96 hours). By invaginating the tissues of the vaginal wall up to or around a uterine artery, collapse of the uterine artery can be achieved without penetrating tissue of the patient.
Owner:VASCULAR CONTROL SYST

Method and device for treating adenomyosis and endometriosis

InactiveUS20070049973A1Simpler and more readily usedSimpler and more readily and removedElectrotherapyBlood flow measurement devicesBlood flowVaginal walls
The invention provides devices, systems and methods for reducing or abolishing blood flow by occluding uterine arteries for treating adenomyosis and endometriosis. A non-invasive uterine artery occlusion device embodying features of the invention includes a pair of pressure-applying members with opposed tissue-contacting surfaces, a supporting shaft configured to adjust the distance between tissue-contacting surfaces, and at least one sensor for locating a uterine artery disposed on at least one pressure-applying member. Uterine arteries are occluded by indirectly compressing the artery by compressing tissue near to an artery. One uterine artery may be occluded or both may be occluded simultaneously. A uterine artery may be accessed via a body cavity, such as a patient's vagina, and may be occluded by compressing a portion of the vaginal wall around a portion of a uterine artery.
Owner:VASCULAR CONTROL SYST

Short term treatment for uterine disorder

InactiveUS20060106109A1Improve biteRetard and prevent lysisBiocidePeptide/protein ingredientsDiseaseUterine Disorder
This invention is directed to a method and device for treating a female patient's uterine disorder by occluding one or both of the patient's uterine artery. The treatment embodying features of the invention basically involves occluding one or both of the patient's uterine arteries with an intravaginal device to form a thrombus within the occluded artery or arteries and administering an agent which will prolong the occlusion of the artery or arteries after removal of the occluding device or initiate or accelerate fibroid cell apoptosis (programmed cell death). The intravaginal device has a pair of pivotally connected occluding members, with at least one of the occluding member having a movable occluding element on a distal shaft section of the occluding member.
Owner:VASCULAR CONTROL SYST

Methods for minimally invasive, non-permanent occlusion of a uterine artery

A method of treating a uterine disorder comprising non-permanently occluding a uterine artery with a resorbable embolic mass for a therapeutically effective time period. The occluding step includes selectively positioning the resorbable embolic mass within the uterine artery, and monitoring positioning of the resorbable embolic mass at a desired location within the uterine artery. The monitoring step may include using ultrasound or magnetic resonance imaging (MRI) for positioning the resorbable embolic mass at the desired location within the uterine artery. The resorbable embolic mass may be swellable and may be formed of a polymeric material selected from the group consisting of polylactic acid, polyglycolic acid, polyethylene glycol, or copolymers thereof.
Owner:VASCULAR CONTROL SYST

Devices and Methods for Ligating Uterine Arteries

InactiveUS20060287658A1Suture equipmentsSurgical needlesCardinal ligamentLigament structure
A system for ligating a uterine artery in a patient generally includes a suture transfer tool, suture transfer darts, and one or more sutures. The suture transfer tool includes an upper jaw that is pivotally joined to a lower jaw. The lower jaw of the tool includes a number of suture capturing pins. The suture transfer darts are configured to be tissue piercing and are positionable within the suture capturing pins. Each end of the suture is connected to a suture transfer dart. When operating the tool, the suture transfer darts pierce through the tissue to either side of a patient's cardinal ligament, which contains the uterine artery, and simultaneously present an end of the suture to either side of the cardinal ligament. As such, the suture is in an open loop configuration about the cardinal ligament and can be tied tight to the ligament to occlude the uterine artery.
Owner:AMS RES CORP

Uterine tissue monitoring device and method

The invention provides a devices, methods and systems to measure and record uterine tissue environment components such as pH during the course of uterine artery occlusion. The uterus becomes ischemic due to the occlusion thereof, and its pH drops sharply within minutes of uterine artery occlusion and remains relatively low for a period of time. The return of normal pH is an indicator of return of blood to the ischemic tissue. In use, a catheter with a pH measuring tip is advanced through the patient's vaginal canal and into the patient's uterine cavity until the pH measuring active electrode on the distal end of the catheter contacts or penetrates the uterine fundus. The active electrode detects the pH and a signal representing pH is transmitted to a pH recording and monitoring device which preferably displays the pH. The signal may be transmitted through a conductor or by a radio transmitter. Components other than pH may be monitored such a pCO2, and pO2.
Owner:VASCULAR CONTROL SYST

Transvaginal uterine artery occlusion for treatment of uterine leiomyomas

InactiveUS20050245947A1Suture equipmentsStaplesArterial occlusionsCardinal ligament
A method for treating uterine leiomyomas, which includes vaginally accessing the cardinal ligament surrounding at least one uterine artery, and occluding the flow of blood through the least one uterine artery. The blood can be occluded by compression. The artery can be compressed by ligating the cardinal ligament. In addition, at least one uterosacral ligament can be ligated. In addition, the artery can be compressed by, clipping, stapling or clamping the cardinal ligament. The blood can also be occluded by coagulating the at least one artery. Coagulation can be done with a laser or a cauterizing device. A system for treating uterine leiomyomas, which includes vaginally accessing the cardinal ligament surrounding at least one uterine artery using a surgical suture passing device to extend a ligature around the ligament, and affixing a ligature around the cardinal ligament to occlude the flow of blood through at least one uterine artery. Also, a system for treating uterine leiomyomas, which includes vaginally accessing the cardinal ligament surrounding at least one uterine artery, providing an absorbable clip and / or staple, and affixing the clip and / or staple around the ligament to occlude the flow of blood through the at least one uterine artery.
Owner:HARMANLI OZ

Uterine Artery Ligation Devices and Methods

InactiveUS20080114382A1Suture equipmentsSurgical needlesCardinal ligamentLigament structure
A system for ligating a uterine artery in a patient generally includes a suture transfer tool, suture transfer darts, and one or more sutures. The suture transfer tool includes an upper jaw that is pivotally joined to a lower jaw. The lower jaw of the tool includes a number of suture capturing pins. The suture transfer darts are configured to be tissue piercing and are positionable within the suture capturing pins. Each end of the suture is connected to a suture transfer dart. When operating the tool, the suture transfer darts pierce through the tissue to either side of a patient's cardinal ligament, which contains the uterine artery, and simultaneously present an end of the suture to either side of the cardinal ligament. As such, the suture is in an open loop configuration about the cardinal ligament and can be tied tight to the ligament to occlude the uterine artery.
Owner:AMS RES CORP

Vascular clamp for caesarian section

The invention provides devices, systems and methods for clamping arteries which are useful in reducing or abolishing blood flow in an artery, and may be used to control hemorrhage following a caesarian delivery. A clamping device embodying features of the invention includes a pair of clamping members with opposed pressure-applying members having facing pressure-applying surfaces, at least one of which is a yieldable pressure-applying surface. The yieldable pressure-applying surface is preferably resilient. The clamping members are configured to adjust the distance between pressure-applying surfaces, and a blood flow sensor is disposed on at least one of the pressure-applying members to aid in locating the target artery and also to monitor blood flow through the artery. The clamping device is particularly suitable for occluding uterine arteries by compressing the broad ligament which contains the uterine artery and which is connected to the patient's uterus with the arterial clamp.
Owner:VASCULAR CONTROL SYST

Fibroid Treatment System and Method

InactiveUS20120271230A1Medical devicesIntravenous devicesMode of actionFibrous Tumor
Various embodiments of a fibroid treatment system and method are provided. Embodiments are adapted to treat fibroids utilizing by blocking or impeding blood flow through the uterine artery to prevent growth of the fibroid. Additionally, drugs or therapeutic agents can be included to further shrink or starve off the fibroid to provide a secondary mode of action.
Owner:AMS RES CORP

Method for producing suppository for treating uterus adenomyosis

A preparation method of suppository for treating uterine adenomyosis mainly solves the problem of suppository material source and product cost. the preparation method comprises (1) cutting aseptic gelatin sponge into thin slices, overlaying, scissoring one end of the sponge into multiple filaments, scissoring into fine particle until to the other end of the sponge, packaging, sterilizing with oxirane, and standing for 2 weeks; (2) dissolving Pingyangmycin 24 mg in physiological saline for operation; and (3) inserting the conduit into one side of the uterine artery, putting the gelatin sponge into a 20mL disposable syringe, decimating the Pingyangmycin physiological saline solution repeatedly, and injecting with the conduit. The method has the advantages of easily-accessible raw materials, low cost, and high security.
Owner:赵传林 +4

Treatment for post partum hemorrhage

InactiveUS20080097473A1Reduce and eliminate hemorrhagingPrecise positioningDiagnosticsSurgical veterinaryBlood flowVaginal canal
The invention is directed to instruments and procedures using such instruments for temporarily reducing or terminating blood flow through a female patient's uterine artery to treat post partum hemorrhage (PPH). The uterine artery is occluded by a clamping device which includes a pair of pivotally connected clamping members, with each of the clamping members having a handle and a clamping element at the distal end of the handle. The clamping elements are inclined with respect to the longitudinal axes of the handles at an included obtuse angle between about 120° and about 170°, preferably between about 130° and 160°. An artery locating sensor is provided on the distal end of at least one of the clamping elements. Preferably, the artery locating sensor is a Doppler ultrasound blood flow sensor. After birth, the clamping device is inserted into the female patient's post partum vaginal canal and advanced therein until one of the clamping elements Is in the patient's uterine cervix and the other clamping element is on the exterior of the uterine cervix. The clamping element on the exterior of the patient's uterine cervix is pressed against the patient's vaginal fornix and the clamping device closed so as to occlude the uterine artery disposed within tissue grasped by the clamping device. The clamping device is locked in the closed configuration and maintained in the condition until the patient's uterus is sufficiently clotted up to ensure termination of the hemorrhaging, typically about 5 minutes to about 7 hours.
Owner:VASCULAR CONTROL SYST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products